These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18324945)

  • 1. Enhanced LDL-C reduction: lower is better. Does it matter how?
    Viljoen A; Wierzbicki AS
    Int J Clin Pract; 2008 Apr; 62(4):518-20. PubMed ID: 18324945
    [No Abstract]   [Full Text] [Related]  

  • 2. [The current debate on lowering LDL cholesterol with ezetimibe].
    Erdmann E
    Dtsch Med Wochenschr; 2010 Sep; 135(36):1742. PubMed ID: 20812160
    [No Abstract]   [Full Text] [Related]  

  • 3. [Type 2 diabetics are high risk patients. Concerning LDL-cholesterol to approach effectively to two sources].
    MMW Fortschr Med; 2005 Nov; 147(44):52-3. PubMed ID: 16302495
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lower LDL and/or raise HDL. In what direction is lipidology moving?].
    Parhofer KG
    MMW Fortschr Med; 2007 May; 149(22):27. PubMed ID: 18069222
    [No Abstract]   [Full Text] [Related]  

  • 5. [New combination therapy. Up to 60% lower LDL cholesterol level].
    MMW Fortschr Med; 2004 May; 146(19):63. PubMed ID: 15357489
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lowering LDL cholesterol frequently does not adhere to guidelines. Also regard intestinal cholesterol source].
    MMW Fortschr Med; 2005 Jun; 147(23):48-9. PubMed ID: 15981908
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of ezetimibe in the management of patients with atherosclerosis.
    Hamilton P
    Coron Artery Dis; 2009 Mar; 20(2):169-74. PubMed ID: 19106797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 10. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
    Olsson AG; Nilsson PM
    Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular risk factor reduction. Cholesterol absorption inhibitors: a new action principle].
    Schunack W
    Pharm Unserer Zeit; 2003; 32(6):498-502. PubMed ID: 14639831
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].
    MMW Fortschr Med; 2008 Jun; 150(23):39. PubMed ID: 18575369
    [No Abstract]   [Full Text] [Related]  

  • 13. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Eichhorn EJ
    N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795
    [No Abstract]   [Full Text] [Related]  

  • 14. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Connor WE
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on the Ezetimibe debate in Chicago.
    Brown JR
    J Clin Lipidol; 2010; 4(4):315-6; discussion 316-7. PubMed ID: 21122667
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study.
    Pauriah M; Struthers AD; Lang CC
    Cardiovasc Ther; 2008; 26(2):85-8. PubMed ID: 18485130
    [No Abstract]   [Full Text] [Related]  

  • 17. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 18. [Horse and rider].
    Heinzl S
    Med Monatsschr Pharm; 2006 Oct; 29(10):353. PubMed ID: 17058893
    [No Abstract]   [Full Text] [Related]  

  • 19. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of lipid disorders.
    Zarowitz BJ; Aronow WS; Hollenack K; O'Shea T
    Geriatr Nurs; 2006; 27(3):142-8. PubMed ID: 16757384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.